Future Oncology · 2021 · 10 citations · 40 references
MedicineOncologyRadiation OncologyCancer ImmunologyTumor ImmunologyTumor ProgressionAntitumor T Cell ResponsesCancer ImmunotherapyCancer Survival AnalysisCytotoxic T Lymphocyte ResponsesImmuno-oncology BiomarkersTumor-infiltrating LymphocytesCd4 Positive T CellsCd8 Positive T CellsCd8+ Tumor-infiltrating LymphocytesFlow Cytometry ImmunophenotypingNaive T CellsNon-small Cell Lung Cancer TreatmentOncologic Outcomes AssessmentPrognostic Indices
Aim: This study aimed to investigate the prognostic value of peripheral naive and memory CD8+ and CD4+ T cells and other immune cells in patients with oligometastatic non-small-cell lung cancer (NSCLC) undergoing radiotherapy (RT). Methods: A total of 142 patients with oligometastatic NSCLC treated with RT were enrolled, and their blood samples were collected within 3 days before RT. Immune cells were identified by flow cytometry. Results: Patients with high levels of naive CD8+ T cells had longer overall survival (p = 0.004) and progression-free survival (p = 0.001) than those with low levels of naive CD8+ T cells. Multivariate analyses revealed that naive CD8+ T cells were independently correlated with overall survival (p = 0.019) and progression-free survival (p = 0.024). Conclusion: The results suggest that peripheral naive CD8+ T cells may be an independent prognostic indicator for patients with oligometastatic NSCLC undergoing RT.
40
Louis Fehrenbacher, Alexander I. Spira, Marcus Ballinger et al. · The Lancet · 2016 · 2.8K citations
Medicine, Oncology, Pharmacology +12
Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing
Xinyi Guo, Yuanyuan Zhang, Liangtao Zheng et al. · Nature Medicine · 2018 · 1.8K citations
Life Sciences, Immunology, Oncology +15
Youjin Lee, Sogyong Auh, Yugang Wang et al. · Blood · 2009 · 1.3K citations · Full text
Medicine, Immunology, Oncology +17
Nael Martini, Myron R. Melamed · Journal of Thoracic and Cardiovascular Surgery · 1975 · 1.3K citations